Skip to content

Clinical trials

Completed Acute Coronary Syndrome trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Not applicable Status: Completed Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20052
20068
20074
20087
20096
201013
201110
201210
201311
201417
201515
201616
201711
20184
201913
20206
202111
20229
20239
20248
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed194

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital10
Wake Forest University Health Sciences6
Assistance Publique Hopitaux De Marseille5
Columbia University5
Mayo Clinic5
Assistance Publique - Hôpitaux de Paris4
Centre Hospitalier Universitaire de Saint Etienne3
Federal University of São Paulo3
Ottawa Heart Institute Research Corporation3
The Miriam Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome194
Myocardial Infarction33
Coronary Artery Disease30
Chest Pain18
Angina, Unstable16
Non-ST Elevated Myocardial Infarction15
Cardiovascular Diseases13
ST Elevation Myocardial Infarction12
Angina, Stable9
Emergencies9

Trials

Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.